monarch bio tech private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 15 September 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 3 bids — CHENNAI METTEX LAB PRIVATE LIMITED appeared in 2 of them.
MONARCH BIO TECH PRIVATE LIMITED
MONARCH BIO TECH PRIVATE LIMITED
Financial Details
Registered Office
17/1, SADULLA STREETT NAGAR CHENNAI 600017NA-CHENNAI 600017-Tamil Nadu-000000-India
Industry Classification
Business Services
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
14
Contract Value
₹4.17 Lakh
L1 Bids
8
Recent Win Rate
100.0%
Performance Analytics
Monarch Bio Tech Private Limited: Government Tender Analysis
Monarch Bio Tech Private Limited has positioned itself as an active participant in the Indian government procurement landscape, submitting bids for 14 government tenders. This tender analysis report provides a comprehensive overview of their key performance metrics, financial health, market positioning, and strategic recommendations, focusing on the period from FY2022-23 to FY2024-25.
Executive Summary
Monarch Bio Tech demonstrates a superior tender success rate of 57.1% based on 14 bids. This impressive win ratio includes securing 8 L1 positions (lowest bid winners). Monarch Bio Tech also has a high qualification rate of 92.9% between April 2018 and March 2025, successfully qualifying for 13 out of 14 tenders, highlighting their strong compliance and understanding of public procurement specifications. However, recent financial health assessment indicates a 'Concerning' score of 48.6/100. This analysis considers metrics like win rate, contract value, bid efficiency, and growth. The assessment highlights recent challenges despite their high qualification rate. While the company shows a 100% win rate in FY2024-25, the overall financial health is concerning due to other factors.
The company shows a focus on engaging with key ministries and departments, particularly the Ministry of Railways and the Department of Food and Public Distribution. Their specialized focus and high win rates in these areas contribute to their competitive positioning in the Indian government tender ecosystem. Recent trend analysis shows that the win rate is strongly improving. Overall, Monarch Bio Tech Private Limited demonstrates mixed financial performance.
Financial Performance Analysis
Monarch Bio Tech's financial performance in government tenders has evolved over the past few fiscal years. Here's a breakdown of their yearly trends:
Year-on-Year Performance: